Resonance Health Limited (ASX:RHT)

Australia flag Australia · Delayed Price · Currency is AUD
0.0400
0.00 (0.00%)
Jul 28, 2025, 2:03 PM AEST
Market Cap18.38M
Revenue (ttm)10.53M
Net Income (ttm)-309.34K
Shares Out459.62M
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume105,021
Average Volume233,873
Open0.0400
Previous Close0.0400
Day's Range0.0400 - 0.0400
52-Week Range0.0340 - 0.0680
Beta1.09
RSI47.68
Earnings DateAug 29, 2025

About Resonance Health

Resonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in Australia, the Asia Pacific, North America, Europe, the Middle East, and Africa. The company offers FerriScan, a non-invasive MRI based solution for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) solution for the automated real-time assessment of LIC; HepaFatScan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; HepaFa... [Read more]

Sector Healthcare
Founded 1987
Employees 16
Stock Exchange Australian Securities Exchange
Ticker Symbol RHT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.